DOSSIER · 13F-HR · Q1 2026

ACUTA CAPITAL PARTNERS, LLC

$142M in tracked AUM across 27 positions as of Q1 2026.

AC
CIK 0001582844 · last filed Mar 31, 2026
Total AUM
$142M
as of Q1 2026
Holdings
27
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

1. Portfolio Overview

ACUTA CAPITAL PARTNERS, LLC manages a focused, high-conviction portfolio totaling approximately $69.02 million as of the report date September 30, 2025. The portfolio decreased by 3.7% from the previous quarter's value of $71.64 million. The fund maintains a highly concentrated structure with only 21 holdings, indicating a strategy that relies on deep, idiosyncratic research rather than broad market diversification.

The portfolio is characterized by high turnover and ...

2. Key Holdings

The portfolio is heavily weighted toward its top-tier positions, with a distinct skew toward companies that may be undervalued or undergoing pivotal transitions.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
PRAX
PRAXIS PRECISION MEDICINES I
$27M85K19.3%
02
TERN
TERNS PHARMACEUTICALS INC
$26M496K18.4%
03
WHWK
WHITEHAWK THERAPEUTICS INC
$12M3.4M8.3%
04
TNGX
TANGO THERAPEUTICS INC
$9M442K6.5%
05
DRUG
BRIGHT MINDS BIOSCIENCES INC
$8M112K5.8%
06
STRO
SUTRO BIOPHARMA INC
$7M269K4.7%
07
ERAS
ERASCA INC
$6M355K4.0%
08
SRZN
SURROZEN INC
$5M173K3.6%
09
OCUL
OCULAR THERAPEUTIX INC
$5M592K3.5%
10
CMPX
COMPASS THERAPEUTICS INC
$4M849K3.2%

Filing history

2026Q1Mar 31
$142M 3.8%
27 positionsView →
2025Q4Dec 31
$147M 113.4%
30 positionsView →
2025Q3Sep 30
$69M 3.7%
21 positionsView →
2025Q2Jun 30
$72M 16.1%
28 positionsLocked
2025Q1Mar 31
$62M 37.9%
27 positionsLocked
2024Q4Dec 31
$99M 19.5%
39 positionsLocked
2024Q3Sep 30
$123M 4.0%
41 positionsLocked
2024Q2Jun 30
$119M 22.9%
33 positionsLocked
2024Q1Mar 31
$154M 13.3%
33 positionsLocked
2023Q4Dec 31
$178M 19.1%
39 positionsLocked
2023Q3Sep 30
$149M 1.1%
46 positionsLocked
2023Q2Jun 30
$148M 8.7%
35 positionsLocked
Showing 12 of 44